Table 1.
Case | Control | p value | |||
---|---|---|---|---|---|
N | % | n | % | ||
Number of subjects | |||||
Gendera | |||||
Male | 244 | 45.1 | 2258 | 44.41 | 0.7566 |
Female | 297 | 54.9 | 2827 | 55.59 | |
Agea,b | 66.93 | 6.8 | 66.79 | 6.91 | 0.6560 |
<65 years old | 175 | 32.35 | 1741 | 34.24 | 0.3777 |
⩾65 years old | 366 | 67.65 | 3344 | 65.76 | |
Duration of follow up (years)a,b | 5.24 | 2.46 | 5.25 | 2.44 | 0.8928 |
<5 | 266 | 49.17 | 2473 | 48.63 | 0.8129 |
⩾5 | 275 | 50.83 | 2612 | 51.37 | |
Hypertension | |||||
No | 365 | 67.47 | 3585 | 70.5 | 0.1424 |
Yes | 176 | 32.53 | 1500 | 29.5 | |
Hyperlipidemia | |||||
No | 467 | 86.32 | 4378 | 86.1 | 0.8854 |
Yes | 74 | 13.68 | 707 | 13.9 | |
Any statin use | |||||
No | 501 | 92.61 | 4791 | 94.22 | 0.1314 |
Yes | 40 | 7.39 | 294 | 5.78 | |
Any antipsychotics use | |||||
No | 503 | 92.98 | 4821 | 94.81 | 0.0722 |
Yes | 38 | 7.02 | 264 | 5.19 |
Matched variables.
Mean and standard deviation.